Gene Therapy for the Treatment of Oral Squamous Cell Carcinoma
- 1 January 2003
- journal article
- other
- Published by SAGE Publications in Journal of Dental Research
- Vol. 82 (1) , 11-16
- https://doi.org/10.1177/154405910308200104
Abstract
Despite advances in surgery, radiotherapy, and chemotherapy, the survival of patients with oral squamous cell carcinoma has not significantly improved over the past several decades. Treatment options for recurrent or refractory oral cancers are limited. Gene therapy for oral cancer is currently under investigation in clinical trials. The goal of cancer gene therapy is to introduce new genetic material into target cells without toxicity to non-target tissues. This review discusses the techniques used in cancer gene therapy for oral squamous cell carcinoma and summarizes the ongoing strategies that are being evaluated in clinical trials.Keywords
This publication has 31 references indexed in Scilit:
- Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivoBiochemical and Biophysical Research Communications, 2002
- A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancerGene Therapy, 2002
- In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancerCancer Gene Therapy, 2002
- Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant gliomaCancer Gene Therapy, 2001
- Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vectorOral Oncology, 2001
- Electroporation Therapy for Head and Neck Cancer Including Carotid Artery InvolvementThe Laryngoscope, 2001
- TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivoGene Therapy, 2000
- Gene Therapy for Head and Neck CancerThe Laryngoscope, 2000
- Cancer Gene TherapySurgical Oncology Clinics of North America, 1998
- p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivoOral Oncology, 1998